Filing Details

Accession Number:
0001214659-20-000466
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-21 18:59:25
Reporting Period:
2020-01-16
Accepted Time:
2020-01-21 18:59:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1076682 Polarityte Inc. PTE Biological Products, (No Disgnostic Substances) (2836) 061529524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1691208 Denver Lough 8 East Broadway, Suite 320
Salt Lake City UT 84111
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock (From Stock Option) Acquisiton 2020-01-16 10,000 $3.12 10,000 No 4 M Indirect Spouse's Employee Stock from Stock Option
Common Stock (From Stock Option) Disposition 2020-01-16 10,000 $4.17 0 No 4 S Indirect Spouse's Employee Stock from Stock Option
Common Stock (From Stock Option) Disposition 2020-01-16 0 $4.14 0 No 4 F Indirect Spouse's Employee Stock from Stock Option
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Spouse's Employee Stock from Stock Option
No 4 S Indirect Spouse's Employee Stock from Stock Option
No 4 F Indirect Spouse's Employee Stock from Stock Option
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2020-01-16 10,000 $0.00 10,000 $3.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2018-12-16 2020-02-15 No 4 M Indirect
Footnotes
  1. On January 16, 2020 the full stock option to exercise 10,000 options at an exercise price of $3.12 was conducted by the Issuer's broker. The resultant converted 10,000 shares were then immediately sold by the Issuer's broker into the open market. The cash proceeds from the sale were used to pay the exercise cost, required tax withholding, brokerage commissions and fees. The sale price of $4.17 represents a weighted average price as multiple executions were involved in completing the exercise transaction. Additional detail regarding the individual execution prices is available upon request.
  2. See prior Form-4 filed on December 19, 2016 (as described in remarks section of this filing)